Aflac Inc (AFL) stock
AFLNYSEAccident & Health InsuranceFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/306% above fair value
$127.61+1.10 (+0.87%)
Close on Nov 13, 2026Market cap $63.98BP/E 18.6Yield 1.82%
Aflac EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Aflac's EPS for the twelve months ending Sep 30, 2026 was $6.86, down 10.4% year over year. For fiscal 2025 it was $6.82, down 29.2% from the year before. Over ten years it grew 8.8% a year on average. The highest annual figure on record is $9.63 in fiscal 2024.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.82 | -29.2% |
| FY2024 | Dec 31, 2024 | $9.63 | +23.8% |
| FY2023 | Dec 31, 2023 | $7.78 | +12.3% |
| FY2022 | Dec 31, 2022 | $6.93 | +10.9% |
| FY2021 | Dec 31, 2021 | $6.25 | -6.3% |
| FY2020 | Dec 31, 2020 | $6.67 | +50.6% |
| FY2019 | Dec 31, 2019 | $4.43 | +17.5% |
| FY2018 | Dec 31, 2018 | $3.77 | -34.7% |
| FY2017 | Dec 31, 2017 | $5.77 | +79.8% |
| FY2016 | Dec 31, 2016 | $3.21 | +9.7% |
| FY2015 | Dec 31, 2015 | $2.92 | -10.0% |
| FY2014 | Dec 31, 2014 | $3.25 | -3.8% |
| FY2013 | Dec 31, 2013 | $3.38 | +10.6% |
| FY2012 | Dec 31, 2012 | $3.06 | +48.3% |
| FY2011 | Dec 31, 2011 | $2.06 | -16.3% |
| FY2010 | Dec 31, 2010 | $2.46 | +54.2% |
| FY2009 | Dec 31, 2009 | $1.59 | +21.8% |
| FY2008 | Dec 31, 2008 | $1.31 | -20.8% |
| FY2007 | Dec 31, 2007 | $1.66 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0.61 | -80.2% |
| Q2 FY2026 | Jun 30, 2026 | $1.63 | +46.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.98 | +3860.0% |
| Q4 FY2025 | Dec 31, 2025 | $2.64 | -22.8% |
| Q3 FY2025 | Sep 30, 2025 | $3.08 | – |
| Q2 FY2025 | Jun 30, 2025 | $1.11 | -64.2% |
| Q1 FY2025 | Mar 31, 2025 | $0.05 | -98.5% |
| Q4 FY2024 | Dec 31, 2024 | $3.42 | +643.5% |
| Q3 FY2024 | Sep 30, 2024 | -$0.17 | -106.4% |
| Q2 FY2024 | Jun 30, 2024 | $3.10 | +14.4% |
| Q1 FY2024 | Mar 31, 2024 | $3.25 | +67.5% |
| Q4 FY2023 | Dec 31, 2023 | $0.46 | +48.4% |
| Q3 FY2023 | Sep 30, 2023 | $2.64 | -6.4% |
| Q2 FY2023 | Jun 30, 2023 | $2.71 | +24.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.94 | +21.2% |
| Q4 FY2022 | Dec 31, 2022 | $0.31 | -78.3% |
| Q3 FY2022 | Sep 30, 2022 | $2.82 | +113.6% |
| Q2 FY2022 | Jun 30, 2022 | $2.17 | +34.0% |
| Q1 FY2022 | Mar 31, 2022 | $1.60 | -14.4% |
| Q4 FY2021 | Dec 31, 2021 | $1.43 | +5.9% |
| Q3 FY2021 | Sep 30, 2021 | $1.32 | -61.6% |
| Q2 FY2021 | Jun 30, 2021 | $1.62 | +44.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.87 | +139.7% |
| Q4 FY2020 | Dec 31, 2020 | $1.35 | +27.4% |
| Q3 FY2020 | Sep 30, 2020 | $3.44 | +230.8% |
| Q2 FY2020 | Jun 30, 2020 | $1.12 | +2.8% |
| Q1 FY2020 | Mar 31, 2020 | $0.78 | -36.6% |
| Q4 FY2019 | Dec 31, 2019 | $1.06 | +53.6% |
| Q3 FY2019 | Sep 30, 2019 | $1.04 | -4.6% |
| Q2 FY2019 | Jun 30, 2019 | $1.09 | +1.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.23 | +35.2% |
| Q4 FY2018 | Dec 31, 2018 | $0.69 | -78.9% |
| Q3 FY2018 | Sep 30, 2018 | $1.09 | +21.1% |
| Q2 FY2018 | Jun 30, 2018 | $1.07 | +20.2% |
| Q1 FY2018 | Mar 31, 2018 | $0.91 | +24.7% |
| Q4 FY2017 | Dec 31, 2017 | $3.27 | +255.4% |
| Q3 FY2017 | Sep 30, 2017 | $0.90 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.89 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.73 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.92 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?